お見積

サンプルお申込み

お問い合わせ

今すぐ購入

※ご注文方法：お問い合わせフォームまたはメールにてご連絡ください。
支払方法：「銀行振込」の場合， 注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期：原則として、受注後2～4営業日以内に発送いたします。 但し、日本語版が必要な場合は、受注後8～10営業日となります。 お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。

本報告書は細胞と遺伝子治療CRO市場規模の世界市場の概要を紹介します。2019~2023年の歴史的な市場収益データ、2024年の予想、および2030年までのCAGRの予測を含む世界市場動向の分析。レポートは細胞と遺伝子治療CROの主要メーカーを詳細に分析し、地域別・国別の収益プロフィールを明らかにしています。 本レポートでは特に、主要地域/国別のセグメントとサブセグメントについて、将来の市場ポテンシャルの探索と予測に焦点を当てています。 複数の地域にわたる包括的なデータと市場価値分析により、読者は包括的かつ詳細な市場洞察を得ることができます。

世界の細胞と遺伝子治療CRO市場の主な参加者である企業概要、収益、粗利益率、ポートフォリオ、地理的位置、重要な発展について、次のパラメータに基づいて説明します。レポートは細胞と遺伝子治療CROのメーカー、地域、種類と端末業界の角度から世界と主要地域の市場現状と将来性を研究した、このレポートでは、世界と主要地域のトップメーカーを分析し、タイプとアプリケーション/端末業界別に細胞と遺伝子治療CRO市場を分類しています。本研究に含まれる主な企業は：Labcorp、IQVIA Biotech、PPD、Medpace、Veristat、Parexel、Charles River Laboratories、Catalent Pharma Solutions、Premier Research、Catalent、Vial、Noble Life Sciences、Ergomed

地域別市場区分、地域別分析は以下の通り：
    アメリカとカナダ
    中国
    アジア
    ヨーロッパ
    中東、アフリカ、ラテンアメリカ

タイプ別市場セグメント：
    Preclinical CRO
    Clinical CRO

用途別の市場セグメント：
    SMBs
    Large Companies

本レポートの詳細内容
世界の細胞と遺伝子治療CRO市場の現状と将来について、グローバルの主要地域を中心に包括的に分析しています。 当レポートでは、多角的な分析を通じて、市場プレイヤー、地域分布、細胞と遺伝子治療CROタイプ、最終用途アプリケーションなどの主要分野を掘り下げ、読者に包括的な市場洞察を提供しています。 レポートは主要企業の細胞と遺伝子治療CRO収益、市場シェア、業界ランキング、2019年から2024年までのデータに焦点を当てています。世界の細胞と遺伝子治療CRO市場における主要なステークホルダーの特定、最近の動向とセグメント収益に基づいて競争状況と市場ポジショニングの分析。また、当レポートでは、世界市場の主要プレイヤーを特定し、プロファイルを作成するとともに、細胞と遺伝子治療CRO市場を綿密に分類・応用することで、読者が市場構造とダイナミクスをより正確に把握できるようにし、十分な情報に基づいた意思決定と戦略立案に強力なサポートを提供しています。

細胞と遺伝子治療CROのレポートは2019年から2030年までのタイプ別およびアプリケーション別、収益、成長率別のセグメントデータを分析します。収益、予測成長傾向、アプリケーション、およびエンドユーザー業界の市場規模を評価および予測します。

章の概要
第1章：細胞と遺伝子治療CROのレポートの報告範囲、各セグメントの市場規模、将来の開発可能性などを含む、さまざまな市場セグメント（製品タイプ、用途など）のエグゼクティブサマリーを紹介します。市場の現状と、短期から中期、および長期的な進化の可能性をハイレベルに見ることができます。（2019～2030）
第2章：細胞と遺伝子治療CROの世界及び地域レベルでの売上高。各地域とその主要国の市場規模と発展の可能性を定量的に分析し、世界各国の市場発展、今後の発展展望、市場空間、生産能力などを紹介する。また、市場ダイナミクス、市場の最新動向、市場の推進要因と制限要因、業界企業が直面する課題とリスク、業界の関連政策の分析などを紹介しています。（2019～2030）
第3章細胞と遺伝子治療CRO企業の競争状況、収益、市場シェアと業界ランキング、最新の開発計画、合併・買収情報などの詳細分析。（2019～2030）
第4章：各市場セグメントの収益と開発の可能性をカバーし、種類別のさまざまな市場セグメントの分析を提供し、読者がさまざまな市場セグメントでブルーオーシャン市場を見つけるのに役立ちます。（2019～2024）
第5章：細胞と遺伝子治療CROの各市場セグメントの収益と開発の可能性をカバーするアプリケーション別のさまざまな市場セグメントの分析を提供し、読者がさまざまな下流市場でブルーオーシャン市場を見つけるのに役立ちます。（2019～2030）
第6章：北米（米国、カナダ）のタイプ別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第7章：ヨーロッパのタイプ別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第8章：中国の種類別、および用途別、各セグメントの収益。（2019～2030）
第9章アジア（中国を除く）の種類別、用途別、地域別、セグメントごとの収益。（2019～2030）
第10章：中東、アフリカ、ラテンアメリカの種類別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第11章：細胞と遺伝子治療CROの主要企業の概要を提供し、製品の説明と仕様、細胞と遺伝子治療CROの収益、粗利益率、最近の展開など、市場の主要企業の基本状況を詳細に紹介します。（2019～2024）
第12章：アナリストの見解/結論

A Cell and Gene Therapy Contract Research Organization (CRO) is a specialized service provider that offers support and expertise in conducting preclinical and clinical research for cell and gene therapy products. These CROs play a crucial role in advancing the development of cell and gene therapies by providing a wide range of services tailored to the unique requirements of these innovative treatments. 
The global Cell and Gene Therapy CRO market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of %during the forecast period.

The US & Canada market for Cell and Gene Therapy CRO is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The China market for Cell and Gene Therapy CRO is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The Europe market for Cell and Gene Therapy CRO is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global key manufacturers of Cell and Gene Therapy CRO include Labcorp, IQVIA Biotech, PPD, Medpace, Veristat, Parexel, Charles River Laboratories, Catalent Pharma Solutions, Premier Research, Catalent, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
Report Includes
This report presents an overview of global market for Cell and Gene Therapy CRO market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Cell and Gene Therapy CRO, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Cell and Gene Therapy CRO, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Cell and Gene Therapy CRO revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Cell and Gene Therapy CRO market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Cell and Gene Therapy CRO revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Labcorp, IQVIA Biotech, PPD, Medpace, Veristat, Parexel, Charles River Laboratories, Catalent Pharma Solutions, Premier Research, Catalent, etc.

Market Segmentation
By Company
    Labcorp
    IQVIA Biotech
    PPD
    Medpace
    Veristat
    Parexel
    Charles River Laboratories
    Catalent Pharma Solutions
    Premier Research
    Catalent
    Vial
    Noble Life Sciences
    Ergomed

Segment by Type
    Preclinical CRO
    Clinical CRO

Segment by Application
    SMBs
    Large Companies

By Region
    North America
        United States
        Canada
    Asia-Pacific
        China
        Japan
        South Korea
        Southeast Asia
        India
        Australia
        Rest of Asia
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
        Nordic Countries
        Rest of Europe
    Latin America
        Mexico
        Brazil
        Rest of South America
    Middle East & Africa
        Turkey
        Saudi Arabia
        UAE
        Rest of MEA

Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Cell and Gene Therapy CRO in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cell and Gene Therapy CRO companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Cell and Gene Therapy CRO revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

List of Tables
 Table 1. Global Cell and Gene Therapy CRO Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
 Table 2. Key Players of Preclinical CRO
 Table 3. Key Players of Clinical CRO
 Table 4. Global Cell and Gene Therapy CRO Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
 Table 5. Global Cell and Gene Therapy CRO Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 6. Global Cell and Gene Therapy CRO Market Size by Region (2019-2024) & (US$ Million)
 Table 7. Global Cell and Gene Therapy CRO Market Share by Region (2019-2024)
 Table 8. Global Cell and Gene Therapy CRO Forecasted Market Size by Region (2025-2030) & (US$ Million)
 Table 9. Global Cell and Gene Therapy CRO Market Share by Region (2025-2030)
 Table 10. Cell and Gene Therapy CRO Market Trends
 Table 11. Cell and Gene Therapy CRO Market Drivers
 Table 12. Cell and Gene Therapy CRO Market Challenges
 Table 13. Cell and Gene Therapy CRO Market Restraints
 Table 14. Global Cell and Gene Therapy CRO Revenue by Players (2019-2024) & (US$ Million)
 Table 15. Global Cell and Gene Therapy CRO Market Share by Players (2019-2024)
 Table 16. Global Top Cell and Gene Therapy CRO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell and Gene Therapy CRO as of 2023)
 Table 17. Global Cell and Gene Therapy CRO Industry Ranking 2022 VS 2023
 Table 18. Global 5 Largest Players Market Share by Cell and Gene Therapy CRO Revenue (CR5 and HHI) & (2019-2024)
 Table 19. Global Key Players of Cell and Gene Therapy CRO, Headquarters and Area Served
 Table 20. Global Key Players of Cell and Gene Therapy CRO, Product and Application
 Table 21. Global Key Players of Cell and Gene Therapy CRO, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global Cell and Gene Therapy CRO Market Size by Type (2019-2024) & (US$ Million)
 Table 24. Global Cell and Gene Therapy CRO Revenue Market Share by Type (2019-2024)
 Table 25. Global Cell and Gene Therapy CRO Forecasted Market Size by Type (2025-2030) & (US$ Million)
 Table 26. Global Cell and Gene Therapy CRO Revenue Market Share by Type (2025-2030)
 Table 27. Global Cell and Gene Therapy CRO Market Size by Application (2019-2024) & (US$ Million)
 Table 28. Global Cell and Gene Therapy CRO Revenue Market Share by Application (2019-2024)
 Table 29. Global Cell and Gene Therapy CRO Forecasted Market Size by Application (2025-2030) & (US$ Million)
 Table 30. Global Cell and Gene Therapy CRO Revenue Market Share by Application (2025-2030)
 Table 31. North America Cell and Gene Therapy CRO Market Size by Type (2019-2024) & (US$ Million)
 Table 32. North America Cell and Gene Therapy CRO Market Size by Type (2025-2030) & (US$ Million)
 Table 33. North America Cell and Gene Therapy CRO Market Size by Application (2019-2024) & (US$ Million)
 Table 34. North America Cell and Gene Therapy CRO Market Size by Application (2025-2030) & (US$ Million)
 Table 35. North America Cell and Gene Therapy CRO Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 36. North America Cell and Gene Therapy CRO Market Size by Country (2019-2024) & (US$ Million)
 Table 37. North America Cell and Gene Therapy CRO Market Size by Country (2025-2030) & (US$ Million)
 Table 38. Europe Cell and Gene Therapy CRO Market Size by Type (2019-2024) & (US$ Million)
 Table 39. Europe Cell and Gene Therapy CRO Market Size by Type (2025-2030) & (US$ Million)
 Table 40. Europe Cell and Gene Therapy CRO Market Size by Application (2019-2024) & (US$ Million)
 Table 41. Europe Cell and Gene Therapy CRO Market Size by Application (2025-2030) & (US$ Million)
 Table 42. Europe Cell and Gene Therapy CRO Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 43. Europe Cell and Gene Therapy CRO Market Size by Country (2019-2024) & (US$ Million)
 Table 44. Europe Cell and Gene Therapy CRO Market Size by Country (2025-2030) & (US$ Million)
 Table 45. China Cell and Gene Therapy CRO Market Size by Type (2019-2024) & (US$ Million)
 Table 46. China Cell and Gene Therapy CRO Market Size by Type (2025-2030) & (US$ Million)
 Table 47. China Cell and Gene Therapy CRO Market Size by Application (2019-2024) & (US$ Million)
 Table 48. China Cell and Gene Therapy CRO Market Size by Application (2025-2030) & (US$ Million)
 Table 49. Asia Cell and Gene Therapy CRO Market Size by Type (2019-2024) & (US$ Million)
 Table 50. Asia Cell and Gene Therapy CRO Market Size by Type (2025-2030) & (US$ Million)
 Table 51. Asia Cell and Gene Therapy CRO Market Size by Application (2019-2024) & (US$ Million)
 Table 52. Asia Cell and Gene Therapy CRO Market Size by Application (2025-2030) & (US$ Million)
 Table 53. Asia Cell and Gene Therapy CRO Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 54. Asia Cell and Gene Therapy CRO Market Size by Region (2019-2024) & (US$ Million)
 Table 55. Asia Cell and Gene Therapy CRO Market Size by Region (2025-2030) & (US$ Million)
 Table 56. Middle East, Africa, and Latin America Cell and Gene Therapy CRO Market Size by Type (2019-2024) & (US$ Million)
 Table 57. Middle East, Africa, and Latin America Cell and Gene Therapy CRO Market Size by Type (2025-2030) & (US$ Million)
 Table 58. Middle East, Africa, and Latin America Cell and Gene Therapy CRO Market Size by Application (2019-2024) & (US$ Million)
 Table 59. Middle East, Africa, and Latin America Cell and Gene Therapy CRO Market Size by Application (2025-2030) & (US$ Million)
 Table 60. Middle East, Africa, and Latin America Cell and Gene Therapy CRO Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 61. Middle East, Africa, and Latin America Cell and Gene Therapy CRO Market Size by Country (2019-2024) & (US$ Million)
 Table 62. Middle East, Africa, and Latin America Cell and Gene Therapy CRO Market Size by Country (2025-2030) & (US$ Million)
 Table 63. Labcorp Company Details
 Table 64. Labcorp Business Overview
 Table 65. Labcorp Cell and Gene Therapy CRO Product
 Table 66. Labcorp Revenue in Cell and Gene Therapy CRO Business (2019-2024) & (US$ Million)
 Table 67. Labcorp Recent Development
 Table 68. IQVIA Biotech Company Details
 Table 69. IQVIA Biotech Business Overview
 Table 70. IQVIA Biotech Cell and Gene Therapy CRO Product
 Table 71. IQVIA Biotech Revenue in Cell and Gene Therapy CRO Business (2019-2024) & (US$ Million)
 Table 72. IQVIA Biotech Recent Development
 Table 73. PPD Company Details
 Table 74. PPD Business Overview
 Table 75. PPD Cell and Gene Therapy CRO Product
 Table 76. PPD Revenue in Cell and Gene Therapy CRO Business (2019-2024) & (US$ Million)
 Table 77. PPD Recent Development
 Table 78. Medpace Company Details
 Table 79. Medpace Business Overview
 Table 80. Medpace Cell and Gene Therapy CRO Product
 Table 81. Medpace Revenue in Cell and Gene Therapy CRO Business (2019-2024) & (US$ Million)
 Table 82. Medpace Recent Development
 Table 83. Veristat Company Details
 Table 84. Veristat Business Overview
 Table 85. Veristat Cell and Gene Therapy CRO Product
 Table 86. Veristat Revenue in Cell and Gene Therapy CRO Business (2019-2024) & (US$ Million)
 Table 87. Veristat Recent Development
 Table 88. Parexel Company Details
 Table 89. Parexel Business Overview
 Table 90. Parexel Cell and Gene Therapy CRO Product
 Table 91. Parexel Revenue in Cell and Gene Therapy CRO Business (2019-2024) & (US$ Million)
 Table 92. Parexel Recent Development
 Table 93. Charles River Laboratories Company Details
 Table 94. Charles River Laboratories Business Overview
 Table 95. Charles River Laboratories Cell and Gene Therapy CRO Product
 Table 96. Charles River Laboratories Revenue in Cell and Gene Therapy CRO Business (2019-2024) & (US$ Million)
 Table 97. Charles River Laboratories Recent Development
 Table 98. Catalent Pharma Solutions Company Details
 Table 99. Catalent Pharma Solutions Business Overview
 Table 100. Catalent Pharma Solutions Cell and Gene Therapy CRO Product
 Table 101. Catalent Pharma Solutions Revenue in Cell and Gene Therapy CRO Business (2019-2024) & (US$ Million)
 Table 102. Catalent Pharma Solutions Recent Development
 Table 103. Premier Research Company Details
 Table 104. Premier Research Business Overview
 Table 105. Premier Research Cell and Gene Therapy CRO Product
 Table 106. Premier Research Revenue in Cell and Gene Therapy CRO Business (2019-2024) & (US$ Million)
 Table 107. Premier Research Recent Development
 Table 108. Catalent Company Details
 Table 109. Catalent Business Overview
 Table 110. Catalent Cell and Gene Therapy CRO Product
 Table 111. Catalent Revenue in Cell and Gene Therapy CRO Business (2019-2024) & (US$ Million)
 Table 112. Catalent Recent Development
 Table 113. Vial Company Details
 Table 114. Vial Business Overview
 Table 115. Vial Cell and Gene Therapy CRO Product
 Table 116. Vial Revenue in Cell and Gene Therapy CRO Business (2019-2024) & (US$ Million)
 Table 117. Vial Recent Development
 Table 118. Noble Life Sciences Company Details
 Table 119. Noble Life Sciences Business Overview
 Table 120. Noble Life Sciences Cell and Gene Therapy CRO Product
 Table 121. Noble Life Sciences Revenue in Cell and Gene Therapy CRO Business (2019-2024) & (US$ Million)
 Table 122. Noble Life Sciences Recent Development
 Table 123. Ergomed Company Details
 Table 124. Ergomed Business Overview
 Table 125. Ergomed Cell and Gene Therapy CRO Product
 Table 126. Ergomed Revenue in Cell and Gene Therapy CRO Business (2019-2024) & (US$ Million)
 Table 127. Ergomed Recent Development
 Table 128. Research Programs/Design for This Report
 Table 129. Key Data Information from Secondary Sources
 Table 130. Key Data Information from Primary Sources


List of Figures
 Figure 1. Global Cell and Gene Therapy CRO Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
 Figure 2. Global Cell and Gene Therapy CRO Market Share by Type: 2023 VS 2030
 Figure 3. Preclinical CRO Features
 Figure 4. Clinical CRO Features
 Figure 5. Global Cell and Gene Therapy CRO Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
 Figure 6. Global Cell and Gene Therapy CRO Market Share by Application: 2023 VS 2030
 Figure 7. SMBs Case Studies
 Figure 8. Large Companies Case Studies
 Figure 9. Cell and Gene Therapy CRO Report Years Considered
 Figure 10. Global Cell and Gene Therapy CRO Market Size (US$ Million), Year-over-Year: 2019-2030
 Figure 11. Global Cell and Gene Therapy CRO Market Size, (US$ Million), 2019 VS 2023 VS 2030
 Figure 12. Global Cell and Gene Therapy CRO Market Share by Region: 2023 VS 2030
 Figure 13. Global Cell and Gene Therapy CRO Market Share by Players in 2023
 Figure 14. Global Top Cell and Gene Therapy CRO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell and Gene Therapy CRO as of 2023)
 Figure 15. The Top 10 and 5 Players Market Share by Cell and Gene Therapy CRO Revenue in 2023
 Figure 16. North America Cell and Gene Therapy CRO Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 17. North America Cell and Gene Therapy CRO Market Share by Type (2019-2030)
 Figure 18. North America Cell and Gene Therapy CRO Market Share by Application (2019-2030)
 Figure 19. North America Cell and Gene Therapy CRO Market Share by Country (2019-2030)
 Figure 20. United States Cell and Gene Therapy CRO Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 21. Canada Cell and Gene Therapy CRO Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 22. Europe Cell and Gene Therapy CRO Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 23. Europe Cell and Gene Therapy CRO Market Share by Type (2019-2030)
 Figure 24. Europe Cell and Gene Therapy CRO Market Share by Application (2019-2030)
 Figure 25. Europe Cell and Gene Therapy CRO Market Share by Country (2019-2030)
 Figure 26. Germany Cell and Gene Therapy CRO Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 27. France Cell and Gene Therapy CRO Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 28. U.K. Cell and Gene Therapy CRO Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 29. Italy Cell and Gene Therapy CRO Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 30. Russia Cell and Gene Therapy CRO Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 31. Nordic Countries Cell and Gene Therapy CRO Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 32. China Cell and Gene Therapy CRO Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 33. China Cell and Gene Therapy CRO Market Share by Type (2019-2030)
 Figure 34. China Cell and Gene Therapy CRO Market Share by Application (2019-2030)
 Figure 35. Asia Cell and Gene Therapy CRO Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 36. Asia Cell and Gene Therapy CRO Market Share by Type (2019-2030)
 Figure 37. Asia Cell and Gene Therapy CRO Market Share by Application (2019-2030)
 Figure 38. Asia Cell and Gene Therapy CRO Market Share by Region (2019-2030)
 Figure 39. Japan Cell and Gene Therapy CRO Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 40. South Korea Cell and Gene Therapy CRO Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 41. China Taiwan Cell and Gene Therapy CRO Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 42. Southeast Asia Cell and Gene Therapy CRO Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 43. India Cell and Gene Therapy CRO Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 44. Australia Cell and Gene Therapy CRO Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 45. Middle East, Africa, and Latin America Cell and Gene Therapy CRO Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 46. Middle East, Africa, and Latin America Cell and Gene Therapy CRO Market Share by Type (2019-2030)
 Figure 47. Middle East, Africa, and Latin America Cell and Gene Therapy CRO Market Share by Application (2019-2030)
 Figure 48. Middle East, Africa, and Latin America Cell and Gene Therapy CRO Market Share by Country (2019-2030)
 Figure 49. Brazil Cell and Gene Therapy CRO Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 50. Mexico Cell and Gene Therapy CRO Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 51. Turkey Cell and Gene Therapy CRO Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 52. Saudi Arabia Cell and Gene Therapy CRO Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 53. Israel Cell and Gene Therapy CRO Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 54. GCC Countries Cell and Gene Therapy CRO Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 55. Labcorp Revenue Growth Rate in Cell and Gene Therapy CRO Business (2019-2024)
 Figure 56. IQVIA Biotech Revenue Growth Rate in Cell and Gene Therapy CRO Business (2019-2024)
 Figure 57. PPD Revenue Growth Rate in Cell and Gene Therapy CRO Business (2019-2024)
 Figure 58. Medpace Revenue Growth Rate in Cell and Gene Therapy CRO Business (2019-2024)
 Figure 59. Veristat Revenue Growth Rate in Cell and Gene Therapy CRO Business (2019-2024)
 Figure 60. Parexel Revenue Growth Rate in Cell and Gene Therapy CRO Business (2019-2024)
 Figure 61. Charles River Laboratories Revenue Growth Rate in Cell and Gene Therapy CRO Business (2019-2024)
 Figure 62. Catalent Pharma Solutions Revenue Growth Rate in Cell and Gene Therapy CRO Business (2019-2024)
 Figure 63. Premier Research Revenue Growth Rate in Cell and Gene Therapy CRO Business (2019-2024)
 Figure 64. Catalent Revenue Growth Rate in Cell and Gene Therapy CRO Business (2019-2024)
 Figure 65. Vial Revenue Growth Rate in Cell and Gene Therapy CRO Business (2019-2024)
 Figure 66. Noble Life Sciences Revenue Growth Rate in Cell and Gene Therapy CRO Business (2019-2024)
 Figure 67. Ergomed Revenue Growth Rate in Cell and Gene Therapy CRO Business (2019-2024)
 Figure 68. Bottom-up and Top-down Approaches for This Report
 Figure 69. Data Triangulation
 Figure 70. Key Executives Interviewed